ACAD
30.93
-0.15
-0.48%
AEMD
1.51
-0.02
-1.31%
APRI
1.45
-0.04
-2.68%
ARNA
20.155
-0.375
-1.827%
ATEC
1.96
+0.04
+2.08%
CNAT
5.109
+0.099
+1.9780%
CRXM
0.163
0.00
0.00%
CYTX
0.313
-0.01
-3.1008%
DXCM
72.52
-0.68
-0.93%
GNMK
9.495
-0.105
-1.094%
HALO
11.84
-0.04
-0.34%
ILMN
190.68
+1.36
+0.72%
INNV
0.116
+0.016
+15.9000%
INO
5.38
-0.07
-1.28%
ISCO
1.25
-0.07
-5.30%
ISIS
57.56
0.00
0.00%
LGND
126.42
+0.16
+0.1266%
LPTN
2.93
-2.93
-100.00%
MBVX
0.53
+0.03
+6.00%
MEIP
2.55
-0.13
-4.85%
MNOV
5
+0.03
+0.60%
MRTX
5.375
-0.225
-4.018%
MSTX
0.13
-0.01
-5.28%
NBIX
51.96
-0.19
-0.36%
NUVA
64.43
+0.37
+0.58%
ONCS
0.89
-0.03
-3.26%
ONVO
1.785
-0.065
-3.514%
OREX
2.37
-0.05
-2.07%
OTIC
20.025
+1.275
+6.800%
QDEL
32.75
+0.14
+0.43%
RCPT
231.96
0.00
0.00%
RGLS
0.83
+0.004
+0.4963%
RMD
73.41
+0.34
+0.47%
SCIE
0
0.00
-33.3333%
SPHS
1.83
-0.07
-3.68%
SRNE
1.725
-0.025
-1.429%
TROV
0.84
+0.011
+1.2896%
VICL
2.35
-0.08
-3.29%
VOLC
18
0.00
0.00%
ZGNX
12
-0.25
-2.04%
ACAD
30.93
-0.15
-0.48%
AEMD
1.51
-0.02
-1.31%
APRI
1.45
-0.04
-2.68%
ARNA
20.155
-0.375
-1.827%
ATEC
1.96
+0.04
+2.08%
CNAT
5.109
+0.099
+1.9780%
CRXM
0.163
0.00
0.00%
CYTX
0.313
-0.01
-3.1008%
DXCM
72.52
-0.68
-0.93%
GNMK
9.495
-0.105
-1.094%
HALO
11.84
-0.04
-0.34%
ILMN
190.68
+1.36
+0.72%
INNV
0.116
+0.016
+15.9000%
INO
5.38
-0.07
-1.28%
ISCO
1.25
-0.07
-5.30%
ISIS
57.56
0.00
0.00%
LGND
126.42
+0.16
+0.1266%
LPTN
2.93
-2.93
-100.00%
MBVX
0.53
+0.03
+6.00%
MEIP
2.55
-0.13
-4.85%
MNOV
5
+0.03
+0.60%
MRTX
5.375
-0.225
-4.018%
MSTX
0.13
-0.01
-5.28%
NBIX
51.96
-0.19
-0.36%
NUVA
64.43
+0.37
+0.58%
ONCS
0.89
-0.03
-3.26%
ONVO
1.785
-0.065
-3.514%
OREX
2.37
-0.05
-2.07%
OTIC
20.025
+1.275
+6.800%
QDEL
32.75
+0.14
+0.43%
RCPT
231.96
0.00
0.00%
RGLS
0.83
+0.004
+0.4963%
RMD
73.41
+0.34
+0.47%
SCIE
0
0.00
-33.3333%
SPHS
1.83
-0.07
-3.68%
SRNE
1.725
-0.025
-1.429%
TROV
0.84
+0.011
+1.2896%
VICL
2.35
-0.08
-3.29%
VOLC
18
0.00
0.00%
ZGNX
12
-0.25
-2.04%
Home » Archive by Category

Syndication

Metacrine Announces Collaboration on Development of FGF1 Variants for Glucose Lowering and Improving Insulin Sensitivity

August 15, 2017 – 4:50 am

SAN DIEGO, Aug. 15, 2017 /PRNewswire/ — Metacrine, Inc., an innovative biotechnology company focused on drug development for metabolic diseases, announced it has entered a collaboration with Novo Nordisk A/S to develop Fibroblast Growth Factor 1 (“FGF1”) variants for glucose lowering and insulin sensitization. 

Metacrine began work on FGF1 following a 2014 seminal study published in the journal Nature, which demonstrated the ability of FGF1 to lower glucose and improve insulin sensitivity in preclinical diabetes models.  Metacrine has made significant progress with protein engineering work to improve the pharmaceutical properties of FGF1.

“We are very pleased to be working with Novo Nordisk, a clear global leader in diabetes and diabetes-related disease complications,” said Ken Song, MD, President and CEO of Metacrine.  “Combining the knowledge and experience of Novo Nordisk with Metacrine’s capabilities ensures an ideal path forward for the FGF1 program, with the opportunity to develop a first-in-class therapeutic to treat patients who have diabetes and other conditions related to insulin resistance.”

Under the terms of the agreement, Metacrine will continue to be responsible for certain research activities to further develop and characterize novel FGF1 variants.  Novo Nordisk will have an option to license the FGF1 program upon achievement of certain research milestones.  Financial terms were not disclosed.

About Metacrine

Metacrine is a privately held biotechnology company headquartered in San Diego, CA. The company is focused on efficiently developing innovative drugs that materially benefit patients with metabolic disease.  For more information, visit www.metacrine.com.

Contact: 
Julie Rathbun
Rathbun Communications
julie@rathbuncomm.com
206.769.9219

 

View original content with multimedia:http://www.prnewswire.com/news-releases/metacrine-announces-collaboration-on-development-of-fgf1-variants-for-glucose-lowering-and-improving-insulin-sensitivity-300504174.html

SOURCE Metacrine, Inc.

Associate Scientist 1 – NGS Assay Development – Illumina – San Diego, CA

August 14, 2017 – 10:45 pm

2+ years biotech industry experience. Design experiments and execute lab work with limited instruction. Perform data analysis and present results to the project…From Illumina – Tue, 15 Aug 2017 06:45:12 GMT – View all San Diego, CA jobs

Senior Manager, Early Clinical Development, Nonclinical Statistics – Pfizer Inc. – La Jolla, CA

August 14, 2017 – 9:53 pm

Experience with multivariate statistics and statistical methods to quantify uncertainty in multi-dimensional data, and with QC procedures for translational and…From Pfizer Inc. – Tue, 15 Aug 2017 05:53:47 GMT – View all La Jolla, CA jobs

Manufacturing Maintenance Engineer – Grifols – San Diego, CA

August 14, 2017 – 8:22 pm

BS in Biomedical or Mechanical Engineering and 2 years’ experience in a regulated biotechnology / medical device industry, or 5 years of relevant work…
From Grifols – Tue, 15 Aug 2017 04:22:35 GMT – View all San Diego, CA jobs

Research Associate – Computational Pathology (6760 Top Gun St, San Diego)

August 14, 2017 – 4:19 pm

Are you a talented research associate looking for a challenging role in an enthusiastic and upbeat small company? Do you work to a high standard and enjoy variety? Reveal Biosciences is a San Diego-based biotech company applying cutting-edge technolo …

Biologist

August 14, 2017 – 2:15 pm

Biologist I – The purpose of the position is to provide technical expertise in the area of pharmaceutical microbiology. The position functions in a cooperative effort to provide quality control and assurance to the operational departments involved in the

Chemist

August 14, 2017 – 2:00 pm

We are looking to fill multiple Chemist positions with entry level and experienced candidates. BS or MS in Chemistry or Biochemistry. Entry level and mid-level positions available – wet lab environment (0-5 years of experience) General Responsibilities: M

Document Control Analyst

August 14, 2017 – 1:50 pm

Summary The main function of the Document Control Analyst is to maintain and modify all required documentation for the company to ensure adherence to the Quality Management System (QMS). Essential Functions Responsible to initiate, review, route, and impl

Lab Technician

August 14, 2017 – 1:41 pm

Essential Duties and Responsibilities: The essential functions include, but are not limited to the following: Responsible for bi-annual pipette and balance/scale calibrations and service Preparation of media, buffer, and antibiotics when common stock leve

Lab Tech- phlebotomist (Carlsbad, CA)

August 14, 2017 – 1:25 pm

Filling/Packaging Lab Technician
A autoimmune company in Carlsbad is looking to add entry level lab Tech’s to their growing team. They would like someone who has a Phlebotomist license for 1 of the roles. They have a couple Lab Tech openings.
Quali …